Ensayo clínico

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT: NCT06898515 · RECRUITING

ID NCTNCT06898515

EstadoRECRUITING

Fecha de inicio2025-07-14

SponsorReprieve Cardiovascular, Inc (INDUSTRY)

First posted2025-03-27

Last updated2026-10-08

Resumen breve

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.